Table 2.
BRAF wild-type (n = 123) | BRAF Mutant (n = 13) | P value | |
Surgery | 0.737 | ||
Yes | 93 (75.6) | 9 (69.2) | |
No | 30 (24.4) | 4 (30.8) | |
Chemotherapy | |||
Yes | 119 (96.7) | 11 (84.6) | |
No | 4 (3.3) | 2 (15.4) | |
Chemotherapy regimen | 0.441 | ||
FOLFOX | 97 (82.2) | 9 (81.8) | |
FOLFIRI | 5 (4.2) | 0 | |
FL | 7 (5.9) | 2 (15.4) | |
Xeloda | 8 (6.8) | 0 | |
SOX | 1 (0.8) | 0 | |
Target agent use | 0.128 | ||
No | 91 (74.0) | 8 (61.5) | |
Bevacizumab | 19 (15.4) | 5 (38.5) | |
Cetuximab | 13 (10.6) | 0 |